ARTICLE | Company News
Vysis licenses disputed patent to bioMerieux
July 10, 2001 7:00 AM UTC
bioMerieux received a license to VYSI's U.S. Patent No. 5,750,338, which covers a method intended to improve clinical sensitivity of enzyme amplification technologies. The Collins patent is the subjec...